Haisco Pharmaceutical Group Co., Ltd.
002653
Rang in Aktien
#2164
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Aktienkurs
$8.28
Marktkapitalisierung
$9.44B
Veränderung (1 Tag)
0.60%
Veränderung (1 Jahr)
12.37%
Land
CN
Handel Haisco Pharmaceutical Group Co., Ltd. (002653)
Kategorie
Healthcare
Operative Marge für Haisco Pharmaceutical Group Co., Ltd. (002653)
Operative Marge zum October 2026 TTM: 13.82%
Laut den neuesten Finanzberichten und dem Aktienkurs von Haisco Pharmaceutical Group Co., Ltd. beträgt die aktuelle operative Marge (TTM) 13.82%. Am Ende des Jahres 2023 lag die operative Marge bei 9.35%.
Historie der operativen Marge von Haisco Pharmaceutical Group Co., Ltd. von 2008 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 13.82% | 1.32% |
| 2024 | 13.64% | 45.88% |
| 2023 | 9.35% | -22.66% |
| 2022 | 12.09% | -34.54% |
| 2021 | 18.47% | -12.01% |
| 2020 | 20.99% | 51.12% |
| 2019 | 13.89% | 46.98% |
| 2018 | 9.45% | -34.05% |
| 2017 | 14.33% | -40.86% |
| 2016 | 24.23% | -27.48% |
| 2015 | 33.41% | -11.00% |
| 2014 | 37.54% | -19.25% |
| 2013 | 46.49% | 6.90% |
| 2012 | 43.49% | -8.52% |
| 2011 | 47.54% | -4.88% |
| 2010 | 49.98% | -10.09% |
| 2009 | 55.59% | -3.81% |
| 2008 | 57.79% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 38.59% | -97.21% |
US
|
|
| -149.01% | -110.78% |
US
|
|
| 25.57% | -98.15% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -97.92% |
NL
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.